A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
Conditions
- Multiple Sclerosis, Relapsing-Remitting
Interventions
- DRUG: Placebo
- DRUG: Ocrelizumab
- DRUG: Avonex
Sponsor
Genentech, Inc.
Collaborators